| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |